Hualan Biological Vaccine Inc.

SZSE:301207 Stok Raporu

Piyasa değeri: CN¥11.1b

Hualan Biological Vaccine Gelecekteki Büyüme

Future kriter kontrolleri 5/6

Hualan Biological Vaccine is forecast to grow earnings and revenue by 33.3% and 28% per annum respectively. EPS is expected to grow by 33.2% per annum. Return on equity is forecast to be 14.6% in 3 years.

Anahtar bilgiler

33.3%

Kazanç büyüme oranı

33.2%

EPS büyüme oranı

Biotechs kazanç büyümesi44.8%
Gelir büyüme oranı28.0%
Gelecekteki özkaynak getirisi14.6%
Analist kapsamı

Low

Son güncelleme18 Sep 2024

Gelecekteki son büyüme güncellemeleri

Hualan Biological Vaccine Inc. Just Missed Revenue By 9.2%: Here's What Analysts Think Will Happen Next

Apr 02
Hualan Biological Vaccine Inc. Just Missed Revenue By 9.2%: Here's What Analysts Think Will Happen Next

Recent updates

Hualan Biological Vaccine (SZSE:301207) Seems To Use Debt Rather Sparingly

Oct 08
Hualan Biological Vaccine (SZSE:301207) Seems To Use Debt Rather Sparingly

Potential Upside For Hualan Biological Vaccine Inc. (SZSE:301207) Not Without Risk

Jul 25
Potential Upside For Hualan Biological Vaccine Inc. (SZSE:301207) Not Without Risk

Hualan Biological Vaccine's (SZSE:301207) Upcoming Dividend Will Be Larger Than Last Year's

Jun 11
Hualan Biological Vaccine's (SZSE:301207) Upcoming Dividend Will Be Larger Than Last Year's

Revenue Downgrade: Here's What Analysts Forecast For Hualan Biological Vaccine Inc. (SZSE:301207)

Apr 03
Revenue Downgrade: Here's What Analysts Forecast For Hualan Biological Vaccine Inc. (SZSE:301207)

Hualan Biological Vaccine Inc. Just Missed Revenue By 9.2%: Here's What Analysts Think Will Happen Next

Apr 02
Hualan Biological Vaccine Inc. Just Missed Revenue By 9.2%: Here's What Analysts Think Will Happen Next

Hualan Biological Vaccine Inc.'s (SZSE:301207) Subdued P/E Might Signal An Opportunity

Apr 01
Hualan Biological Vaccine Inc.'s (SZSE:301207) Subdued P/E Might Signal An Opportunity

An Intrinsic Calculation For Hualan Biological Vaccine Inc. (SZSE:301207) Suggests It's 31% Undervalued

Mar 04
An Intrinsic Calculation For Hualan Biological Vaccine Inc. (SZSE:301207) Suggests It's 31% Undervalued

Kazanç ve Gelir Büyüme Tahminleri

SZSE:301207 - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (CNY Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
12/31/20263,6571,344N/A1,2093
12/31/20253,1161,114N/A1,0614
12/31/20242,644929N/A1,1134
9/30/20241,650498695750N/A
6/30/20242,296777688749N/A
3/31/20242,300805724792N/A
12/31/20232,410860825888N/A
9/30/20231,984645752813N/A
6/30/2023915330667732N/A
3/31/20231,956614459533N/A
1/1/20231,826520196289N/A
9/30/20221,997598-162233N/A
6/30/20222,879948-254184N/A
3/31/20221,833624-216274N/A
1/1/20221,830621-67569N/A
9/30/20212,6081,004124608N/A
6/30/20212,441922360946N/A
3/31/20212,439934285897N/A
12/31/20202,426925161694N/A
12/31/20191,049375131275N/A
12/31/20188032703294N/A
12/31/2017285-77N/A22N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: 301207's forecast earnings growth (33.3% per year) is above the savings rate (2.9%).

Kazançlar ve Piyasa: 301207's earnings (33.3% per year) are forecast to grow faster than the CN market (25.8% per year).

Yüksek Büyüme Kazançları: 301207's earnings are expected to grow significantly over the next 3 years.

Gelir ve Pazar: 301207's revenue (28% per year) is forecast to grow faster than the CN market (14% per year).

Yüksek Büyüme Geliri: 301207's revenue (28% per year) is forecast to grow faster than 20% per year.


Hisse Başına Kazanç Büyüme Tahminleri


Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: 301207's Return on Equity is forecast to be low in 3 years time (14.6%).


Büyüyen şirketleri keşfedin